Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
Student Mick van der Spoel wint Philips AI scriptieprijs voor hersentumoronderzoek
nov 2021 | Neuro-oncologie